^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Ximotini (simotinib)

    i
    Other names: SIM6802, AL-6802, SIM-6802, AL6802
    Associations

    News

    Trials
    Company:
    Advenchen, Simcere
    Drug class:
    EGFR inhibitor
    Related drugs:
    Associations

    News

    Trials
    over5years
    Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC (clinicaltrials.gov)
    P1, N=30, Recruiting, Jiangsu Simcere Pharmaceutical Co., Ltd.
    Clinical • New P1 trial
    |
    EGFR (Epidermal growth factor receptor)
    |
    EGFR mutation • EGFR L858R • EGFR exon 19 deletion • EGFR L861Q • EGFR G719X
    |
    Ximotini (simotinib)